TLR4 agonists as vaccine adjuvants: achemist's perspective

被引：13
作者：
Johnson, David A. [1 ]
机构：
[1] GlaxoSmithKline Vaccines, Hamilton, MT 59840 USA
来源：
EXPERT REVIEW OF VACCINES | 2013年 / 12卷 / 07期
关键词：
AGP; aminoalkyl glucosaminide phosphate; lipid A mimetic; TLR4; agonist; TRIF selectivity; vaccine adjuvant; MONOPHOSPHORYL-LIPID-A; PATHWAYS;
D O I：
10.1586/14760584.2013.811189
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：711 / 713
页数：3
相关论文
共 50 条
  • [1] The science of vaccine adjuvants: advances in TLR4 ligand adjuvants
    Reed, Steven G.
    Hsu, Fan -Chi
    Carter, Darrick
    Orr, Mark T.
    CURRENT OPINION IN IMMUNOLOGY, 2016, 41 : 85 - 90
  • [2] Effect of combination adjuvants composed of aluminium salts and TLR4 agonists on the immune response
    Sokolovska, A.
    HogenEsch, H.
    VACCINE, 2008,
  • [3] Synthetic glycan-based TLR4 agonists targeting caspase-4/11 for the development of adjuvants and immunotherapeutics
    Adanitsch, Florian
    Shi, Jianjin
    Shao, Feng
    Beyaert, Rudi
    Heine, Holger
    Zamyatina, Alla
    CHEMICAL SCIENCE, 2018, 9 (16) : 3957 - 3963
  • [4] Overcoming Challenges in Chemical Glycosylation to Achieve Innovative Vaccine Adjuvants Possessing Enhanced TLR4 Activity
    Romerio, Alessio
    Franco, Ana Rita
    Shadrick, Melanie
    Shaik, Mohammed Monsoor
    Artusa, Valentina
    Italia, Alice
    Lami, Federico
    Demchenko, Alexei V.
    Peri, Francesco
    ACS OMEGA, 2023, 8 (39): : 36412 - 36417
  • [5] TLR Agonists as Adjuvants for Cancer Vaccines
    Li, Ji-Kun
    Balic, Jesse J.
    Yu, Liang
    Jenkins, Brendan
    REGULATION OF INFLAMMATORY SIGNALING IN HEALTH AND DISEASE, 2017, 1024 : 195 - 212
  • [6] Synthetic TLR4-active glycolipids as vaccine adjuvants and stand-alone immunotherapeutics
    Johnson, David A.
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2008, 8 (02) : 64 - 79
  • [7] Immune profile diversity is achieved with synthetic TLR4 agonists combined with the RG1-VLP vaccine in mice
    Matthews, Rebecca L.
    Khan, Nazneen
    Beckman, Bradley
    Sharma, Simran
    Dietz, Zackary
    Picking, William D.
    Izmirlian, Grant
    Sanders, Chelsea
    Stocks, Stacy M.
    Difilippantonio, Simone
    Kirnbauer, Reinhard
    Roden, Richard B.
    Pinto, Ligia A.
    Shoemaker, Robert H.
    Ernst, Robert K.
    Marshall, Jason D.
    VACCINE, 2025, 44
  • [8] Physicochemical characterization of biological and synthetic forms of two lipid A-based TLR4 agonists
    Hu, Gang
    Varisco, David J.
    Das, Sayan
    Middaugh, C. Russell
    Gardner, Francesca
    Ernst, Robert K.
    Picking, Wendy L.
    Picking, William D.
    HELIYON, 2023, 9 (07)
  • [9] Exploring TLR agonists as adjuvants for COVID-19 oral vaccines
    Felix, Paulo
    Melo, Alexandra A.
    Costa, Joao Panao
    Colaco, Mariana
    Pereira, Dina
    Nunez, Jisette
    de Almeida, Luis Pereira
    Borges, Olga
    VACCINE, 2025, 53
  • [10] A lipid A-based TLR4 mimetic effectively adjuvants a Yersinia pestis rF-V1 subunit vaccine in a murine challenge model
    Gregg, Kelsey A.
    Harberts, Erin
    Gardner, Francesca M.
    Pelletier, Mark R.
    Cayatte, Corinne
    Yu, Li
    McCarthy, Michael P.
    Marshall, Jason D.
    Ernst, Robert K.
    VACCINE, 2018, 36 (28) : 4023 - 4031
12345